AGP Picks
View all

The Albany Post: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Albany Post.

Press releases published on July 7, 2026

XWELL Announces Definitive Agreement to Divest XpresSpa and XpresTest Businesses
Peak Power Brings 3.6 MW Battery Energy Storage Project Online at Vuteq Canada’s Woodstock Manufacturing Facility
Choosing a WordPress or Drupal Development Company
Bloomberg Media and Muck Rack Launch Integration to Bring Bloomberg Journalism into PR Workflows
Carson Wealth Expands Northern Kentucky Presence with Integration of FFR Wealth Team
CMMB Expands Global NCD Initiative into Nigeria, Advancing Global Scale
Digital Dental Lab Dandy Appoints Head of Product to Accelerate AI-Powered Innovation
HUMAN Security Disrupts CTV Device Spoofing Operation "NewsJunkie"
Profound Launches Ads Studio, Helping Marketers Generate and Optimize Advertising Campaigns Across AI Search Platforms
Data Storage Corporation Appoints AI and Cybersecurity Veteran Jerome Naidoo as Strategic Advisor
CPI Aero Secures $8.3 Million in New U.S. Air Force Orders for T-38 Aircraft Modification Kits
Kingstone to Launch Proactive Electrical Fire Prevention Program for New York Policyholders
Syntec Optics (NASDAQ: OPTX) Secures 40% Increase in Orders for Missile Laser Guidance Product Line
Bright Power Earns 2026 Great Place To Work Certification
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas
EliseAI Announces Elise Beyond Conference for Multifamily Operators to Unlock AI’s Full Potential
National Healthcare Properties Provides Transaction Updates
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)
Plug Wins 50MW Electrolyzer Order as Orica's Hunter Valley Hub Becomes the Largest Australian Renewable Hydrogen Project to Reach FID
Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Albany Post

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.